{"id":"W4200026444","doi":"10.1158/1535-7163.targ-21-lba020","title":"Abstract LBA020: Targeting FGFR2c isoform, a novel therapeutic target with FGFR inhibitor in endometrial cancer","year":2021,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Endometrial cancer; Oncology; Cancer; Medicine; Internal medicine; Gene isoform; Cohort; Clinical trial; Disease; Alternative splicing; Cancer research; Biology; Gene","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000319071,0.0004652387,0.0004211606,0.0001838318,0.0001167769,0.0001153611,0.0004082713,0.0003353671,0.0002864604],"category_scores_gemma":[0.00005695444,0.0004234209,0.0001978232,0.0008416442,0.0001812305,0.00001857006,0.0001957753,0.0005499254,0.000009691031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002011417,"about_ca_system_score_gemma":0.001178482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002871545,"about_ca_topic_score_gemma":0.0004682072,"domain_scores_codex":[0.9969277,0.0001290745,0.0004773909,0.0008620853,0.0006560628,0.0009477077],"domain_scores_gemma":[0.9986706,0.00004740968,0.0001738075,0.000588457,0.0003469369,0.0001728019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006608495,0.0002453913,0.01243094,0.00008393492,0.0004501724,0.00008897257,0.0001266755,0.001741674,0.9800127,0.0000566999,0.00008599262,0.004016028],"study_design_scores_gemma":[0.003702119,0.0002989338,0.00605729,0.0001199294,0.00005395195,0.00001700655,0.0001346677,0.0002241343,0.9437007,0.000060191,0.04501923,0.0006118322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676985,0.02375465,0.005870157,0.0009848606,0.0004251992,0.0006047833,0.0001594463,0.00003917328,0.0004632352],"genre_scores_gemma":[0.994002,0.001359183,0.001858258,0.001526946,0.0004463401,0.0002468913,0.0001581268,0.0001545861,0.0002476352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04493324,"threshold_uncertainty_score":0.9998218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02507841938843143,"score_gpt":0.3026499582272994,"score_spread":0.277571538838868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}